Acute atherosis and diffuse lipid infiltration of the placental bed: A review of historical lipid studies

Placenta ◽  
2020 ◽  
Vol 97 ◽  
pp. 36-41
Author(s):  
Ivo Brosens ◽  
Jan J. Brosens ◽  
Joanne Muter ◽  
Giuseppe Benagiano
Keyword(s):  
1975 ◽  
Vol 123 (2) ◽  
pp. 164-174 ◽  
Author(s):  
F. De Wolf ◽  
W.B. Robertson ◽  
I. Brosens

2021 ◽  
Author(s):  
Peilin Zhang

Background: There are three types of decidual vasculopathy, namely, acute atherosis, fibrinoid medial necrosis and mural arterial hyerptrophy. Persistence of vascular trophoblasts is also known to be related to maternal vascular malperfusion, but detailed study is lacking. Material and methods: A total 1017 placentas from 2021 were collected with clinical, neonatal and placental information, and routine placental pathology examination was performed. Decidual vasculopathy was classified based on the new classification scheme including atherosis of macrophage type atherosis of trophoblast type, fibrinoid medial necrosis, mural arterial hypertrophy and mixed type vasculopathy. The significance of these morphologic changes were examined based on the clinical, neonatal and placental pathology features. Results: Decidual vasculopathy is classified as classic type, mural hypertrophy and mixed type. Classic type vasculopathy is further separated as atherosis and fibrinoid medial necrosis. Atherosis is defined as atherosis of macrophage type and atherosis of trophoblast type. Each category of decidual vasculopathy was evaluated in association with maternal, neonatal and placental pathologic findings. Atherosis of macrophage type and mixed type vasculopathy showed statistically significant association with preeclampsia/pregnancy induced hypertension, low birth weight and low placental weight. Atherosis of trophoblast type was associated with lower placental weight but not with specific clinical features. There is no neonatal sex dimorphism in decidual vasculopathy. Conclusion: Atherosis of trophoblast type is a distinct pathologic feature in late pregnancy, and it is associated with lower placental weight. New classification of decidual vasculopathy helps with better stratification and categorization of placental maternal vascular abnormalities.


Hypertension ◽  
2018 ◽  
Vol 72 (3) ◽  
pp. 695-702 ◽  
Author(s):  
Kjartan Moe ◽  
Patji Alnaes-Katjavivi ◽  
Gro L. Størvold ◽  
Meryam Sugulle ◽  
Guro M. Johnsen ◽  
...  

Placenta ◽  
2016 ◽  
Vol 37 ◽  
pp. 26-33 ◽  
Author(s):  
Patji Alnaes-Katjavivi ◽  
Fiona Lyall ◽  
Borghild Roald ◽  
Christopher W.G. Redman ◽  
Anne Cathrine Staff

Placenta ◽  
2007 ◽  
Vol 28 (8-9) ◽  
pp. 958-964 ◽  
Author(s):  
N.K. Harsem ◽  
B. Roald ◽  
K. Braekke ◽  
A.C. Staff

Lupus ◽  
1998 ◽  
Vol 7 (2_suppl) ◽  
pp. 81-85 ◽  
Author(s):  
RA Levy ◽  
E Avvad ◽  
J Oliveira ◽  
LC Porto

One of the major targets of antiphospholipid antibodies (aPL) is the placenta, the evolution of which during pregnancy has been well documented. Histopathological findings are related to gestational age, and several physiologic and pathologic alterations that occur during its development. The major findings in placentae from aPL positive patients are thrombosis, acute atherosis, a decreased number of syncytio-vascular membranes, increased number of syncytial knots and obliterative arteriopathy. These findings are not specific to the antiphospholipid syndrome (APS) and sometimes do not correlate with the fetal outcome. Histopathological study of placentae may elucidate mechanisms of action of aPL in fetal loss and other obstetric complications. In addition, it may assist in the investigation of the differential diagnosis between APS and pregnancy-induced hypertension. Immunohistochemical studies of local placental proteins contribute to this differential diagnosis.


Placenta ◽  
2014 ◽  
Vol 35 (9) ◽  
pp. A12-A13
Author(s):  
Patji Alnæs-Katjavivi ◽  
Fiona Lyall ◽  
Borghild Roald ◽  
Christopher Redman ◽  
Annetine Staff

Sign in / Sign up

Export Citation Format

Share Document